Michigan Journal of Public Health
Volume 4 | Issue 1

Article 10

2010

Development of a CBPR Protocol for an IDU
Focus Group on Overdose Prevention and
Naloxone Training & Distribution
Julie Gleason-Comstock
Wayne State University, jgleason@med.wayne.edu

Follow this and additional works at: http://scholarworks.gvsu.edu/mjph
Part of the Public Health Commons
Recommended Citation
Gleason-Comstock, Julie (2010) "Development of a CBPR Protocol for an IDU Focus Group on Overdose Prevention and Naloxone
Training & Distribution," Michigan Journal of Public Health: Vol. 4 : Iss. 1 , Article 10.
Available at: http://scholarworks.gvsu.edu/mjph/vol4/iss1/10

This Article is brought to you for free and open access by ScholarWorks@GVSU. It has been accepted for inclusion in Michigan Journal of Public
Health by an authorized editor of ScholarWorks@GVSU. For more information, please contact scholarworks@gvsu.edu.

Development of a CBPR Protocol for an IDU Focus Group on
Overdose Prevention and Naloxone Training & Distribution
Julie Gleason-Comstock, PhD, CHES
Wayne State University (WSU) Department of Family Medicine &
Public Health Sciences and Center for Urban Studies (CUS), Office of the Provost
Opioid overdose is a leading cause of death among injection drug users (IDU). Naloxone is an
effective opiate antagonist used by medical personnel for emergency resuscitation. To provide
guidance for an urban public health initiative on naloxone training and distribution, a
community health organization which operates a syringe exchange program, a local health
department and a research university used an existing Community-Based Participatory Research
(CBPR) relationship to develop a focus group protocol to receive input from IDU.
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BACKGROUND

METHODS

Opiod overdose is a leading cause of death among injection drug
users (IDU). Naloxone is an effective opiate antagonist used by medical
personnel for over thirty years for emergency resuscitation. Except for
potential dope sickness, the drug has no side effects and no
pharmacological effect when opiates are absent.

In preparation
to implement this program, sixteen intravenous drug
.
users (IDU), all registered members of the Life Points program, participated
in one of two focus groups. Questions explored the IDU typical injecting
environment, experiences with drug overdose and their opinions about using
naloxone in the community. Prior to the group, all participants completed a
brief survey and watched a 10 minute video about naloxone.

Recently community-based harm reduction programs have
developed a training and distribution program in which injecting drug
users themselves can administer naloxone in case of opiate overdose.
Although it does not completely eliminate the need for medical
intervention, the program can prevent unnecessary death from opiate
overdose by allowing trained bystanders to inject naloxone immediately
instead of using multiple ineffective methods to revive someone before
calling 911. Studies show that injecting drug users are willing to and
do use the naloxone to prevent overdose death and that it does not
increase the frequency or quantity of opiates used .
Presentation: Michigan’s Premier Public Health Conference, 2009

INTRODUCTION
A Community-Based Participatory Research collaborative
between the City of Detroit Department of Health and Wellness
Promotion , Community Health Awareness Group , Inc. and
researchers from the WSU Center for Urban Studies , Office of the
Provost, and the Department of Family Medicine & Public Health
Sciences , School of Medicine, explored the feasibility of adapting the
Chicago Recovery Alliance model for prevention of opiate overdose
related death in the City of Detroit.
The opiate reversal program is planned as a natural expansion
of services provided through CHAG’s Life Points Harm Reduction
Outreach program. Life Points has provided syringe exchange,
HIV/AIDS and Hepatitis C risk reduction education, referrals to drug
treatment and HIV/AIDS testing to injecting drug users and others
through mobile street outreach since 1996. The naloxone distribution
program will be implemented through Life Points in late 2009.

PARTICIPANT CHARACTERISTICS

RESULTS
INJECTING ENVIRONMENTS
• 80% of the respondents said they inject primarily in private locations
• Usually with friends and in their own homes
• 44% usually inject with a regular injecting partner
• Only 25% ever injected in a shooting gallery.
• 31% always inject alone
• Most like privacy when using; don’t like others watching while inject
• Many expressed feeling safe when they get high by themselves because
they can’t afford enough dope to put them over the top or they always
buy from someone they know.

• 56% Female
• Race/Ethnicity
• 44% African-American
• 38% White, non Hispanic
• 12% White, Hispanic
• 6% American Indian

OVERDOSE EXPERIENCES IN THE LAST 12 MONTHS
• 75% knew someone who overdosed at least once
• 19% had overdosed themselves
• Most often the OD occurred in their own house
Seeking Services from the Life Points Van

• Age
• 25- 30 (12%)
• 31- 39 (12%)
• 40 – 49 (38%)
• 50 + (38%)

USUAL RESPONSES TO OVERDOSE

• Education
• 8th grade or less (13%)
• Some high school (25%)
• High school graduate/GED (38%)
• College (25%)
Age When Started Injecting
40 or older
14%

13-20 years
26%

30-39 years
26%

• Actions taken
• Shake or slap them around
• Walk them around
• Place ice water on genitals; keep temperature down
• Rescue Breathing
• Reasons for inaction: fear of arrest
• “People end up dying (from overdose) because people are afraid they
will be charged with murder or maybe they have warrants so they
don’t want to take them to the hospital.”
• “They should have amnesty like you have for babies for people who
OD. You could be charged for murder. Ease up on people when they
drop off someone who OD’d”

21-29 years
34%

WILLINGNESS TO USE NALOXONE AND INFORM OTHERS
Length of Time in Syringe Exchange Program

5 or more
years
15%

< 1 year
35%

4 years
28%

3 years
15%

2 years
7%

• 100% were willing to carry and use naloxone when witnessing an OD
• “Even if I was high... it would wake me up, blow my high so I would be
able to deal with it.”
• “You can work it out with someone where you say” I’ve got this and you
give that so that if one of us falls out, you can hit me… ”
• “Hey we still have a heart and conscience, even if we don’t know each
other, we would do it.”

Acknowledgement: Chicago Recovery Alliance

